Literature DB >> 29684120

Atrial fibrillation in patients with inherited cardiomyopathies.

Cynthia Yeung1, Andres Enriquez1, Laiden Suarez-Fuster1, Adrian Baranchuk1.   

Abstract

Atrial fibrillation (AF) often complicates the course of inherited cardiomyopathies and, in some cases, may be the presenting feature. Each inherited cardiomyopathy has its own peculiar pathogenetic characteristics that can contribute to the development and maintenance of AF. Atrial fibrillation may occur as a consequence of disease-specific defects, non-specific cardiac chamber changes secondary to the primary illness, or a combination thereof. The presence of AF can denote a turning point in the progression of the disease, promoting clinical deterioration and increasing morbidity and mortality. Furthermore, the management of AF can be particularly challenging in patients with inherited cardiomyopathies. In this article, we review the current information on the prevalence, pathophysiology, risk factors, and treatment of AF in three different inherited cardiomyopathies: hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy, familial dilated cardiomyopathy, and left ventricular non-compaction cardiomyopathy.

Entities:  

Year:  2019        PMID: 29684120     DOI: 10.1093/europace/euy064

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

Review 1.  Arrhythmias as Presentation of Genetic Cardiomyopathy.

Authors:  J Lukas Laws; Megan C Lancaster; M Ben Shoemaker; William G Stevenson; Rebecca R Hung; Quinn Wells; D Marshall Brinkley; Sean Hughes; Katherine Anderson; Dan Roden; Lynne W Stevenson
Journal:  Circ Res       Date:  2022-05-26       Impact factor: 23.213

Review 2.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

3.  Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review.

Authors:  Thomas Eschenhagen; Lucie Carrier
Journal:  Pflugers Arch       Date:  2018-10-15       Impact factor: 3.657

Review 4.  A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy.

Authors:  Cristina Chimenti; Carlo Lavalle; Michele Magnocavallo; Maria Alfarano; Marco Valerio Mariani; Federico Bernardini; Domenico Giovanni Della Rocca; Gioacchino Galardo; Paolo Severino; Luca Di Lullo; Fabio Miraldi; Francesco Fedele; Andrea Frustaci
Journal:  ESC Heart Fail       Date:  2021-12-16

5.  Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data.

Authors:  Benjamin J R Buckley; Stephanie L Harrison; Dhiraj Gupta; Elnara Fazio-Eynullayeva; Paula Underhill; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 5.501

Review 6.  Arrhythmogenic Right Ventricular Cardiomyopathy: The Role of Genetics in Diagnosis, Management, and Screening.

Authors:  Mihir Odak; Steven Douedi; Anton Mararenko; Abbas Alshami; Islam Elkherpitawy; Hani Douedi; Eran Zacks; Brett Sealove
Journal:  Cardiol Res       Date:  2022-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.